Takeda Pharmaceutical Company Limited
Heterocyclic compound

Last updated:

Abstract:

The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the specification, or a salt thereof.

Status:
Grant
Type:

Utility

Filling date:

24 Aug 2016

Issue date:

10 Sep 2019